KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019)

Historic Amortizatization of Intangibles for Aquestive Therapeutics (AQST) over the last 3 years, with Q3 2019 value amounting to $13000.0.

  • Aquestive Therapeutics' Amortizatization of Intangibles changed 0.0% to $13000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $88000.0, marking a year-over-year decrease of 329.67%. This contributed to the annual value of $130000.0 for FY2018, which is 655.74% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Amortizatization of Intangibles of $13000.0 as of Q3 2019, which was down 0.0% from $13000.0 recorded in Q2 2019.
  • Aquestive Therapeutics' Amortizatization of Intangibles' 5-year high stood at $34000.0 during Q1 2018, with a 5-year trough of $12000.0 in Q2 2018.
  • Over the past 3 years, Aquestive Therapeutics' median Amortizatization of Intangibles value was $28000.0 (recorded in 2018), while the average stood at $23333.3.
  • Per our database at Business Quant, Aquestive Therapeutics' Amortizatization of Intangibles crashed by 5806.45% in 2018 and then skyrocketed by 833.33% in 2019.
  • Over the past 3 years, Aquestive Therapeutics' Amortizatization of Intangibles (Quarter) stood at $32000.0 in 2017, then dropped by 12.5% to $28000.0 in 2018, then tumbled by 53.57% to $13000.0 in 2019.
  • Its last three reported values are $13000.0 in Q3 2019, $13000.0 for Q2 2019, and $34000.0 during Q1 2019.